Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class ASSE: 688488

"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Progress of Acquisition of the Minority Shareholder's Equity Interests in Controlled Subsidiary

Aug 13, 2026 · Issued by Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Progress of Acquisition of the Minority Shareholder's Equity Interests in Controlled Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A

"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Use of Own Funds, Bank Acceptance Bills and Other Methods to Pay Funds Required for Raised Fund Investment Projects and Equivalent Replacement with Raised FundsJul 31
"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Cancellation of Certain Dedicated Settlement Accounts for Wealth Management Products Purchased with Raised FundsJul 25
"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Voluntary Disclosure of Obtaining of Drug Registration Approval for Darunavir TabletsJul 24
"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial for ADC119 TabletsJul 9

All Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A news releases